Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assunta Ingannato

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Clinical Neurology and Neurosurgery|July 13, 2023
Sex influences clinical phenotype in valosin-containing protein mutations: A case family report and systematic literature reviewDeborah Leccese, Gabriele Rosario Rodolico, Martina Sperti, et al.
Annals of Clinical and Translational Neurology|September 10, 2025
Plasma p-tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal StudyGiulia Giacomucci, Assunta Ingannato, Chiara Crucitti, et al.
Journal of Personalized Medicine|January 20, 2021
Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer's Disease and Frontotemporal DementiaGiulia Giacomucci, Salvatore Mazzeo, Silvia Bagnoli, et al.
Frontiers in Psychiatry|April 4, 2022
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up StudyValentina Moschini, Salvatore Mazzeo, Silvia Bagnoli, et al.
Journal of the Neurological Sciences|September 16, 2023
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive ImpairmentGiulia Giacomucci, Salvatore Mazzeo, Chiara Crucitti, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 13, 2025
The two cut-offs approach for plasma p-tau217 in detecting Alzheimer's disease in subjective cognitive decline and mild cognitive impairmentGiulia Giacomucci, Chiara Crucitti, Assunta Ingannato, et al.
Neuroimage. Clinical|August 2, 2025
Beyond language: empathy and emotion recognition deficits in primary progressive aphasiasGiulia Giacomucci, Alice Pieri, Valentina Moschini, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 17, 2026
Refining Alzheimer's disease biological diagnosis with plasma biomarkers: Resolving p-tau217 "gray zone" with p-tau181 integrationGiulia Giacomucci, Silvia Maria Rita Tabbì, Assunta Ingannato, et al.
International Journal of Molecular Sciences|July 13, 2024
Mutational Landscape of Alzheimer's Disease and Frontotemporal Dementia: Regional Variances in Northern, Central, and Southern ItalyClaudia Saraceno, Lorenzo Pagano, Valentina Laganà, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 16, 2025
"Assessing relationship between blood MAPT methylation levels and clinical expression in Frontotemporal Dementia"Gemma Lombardi, Silvia Bagnoli, Assunta Ingannato, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Clinical Neurology and Neurosurgery|July 13, 2023
Sex influences clinical phenotype in valosin-containing protein mutations: A case family report and systematic literature reviewDeborah Leccese, Gabriele Rosario Rodolico, Martina Sperti, et al.
Annals of Clinical and Translational Neurology|September 10, 2025
Plasma p-tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal StudyGiulia Giacomucci, Assunta Ingannato, Chiara Crucitti, et al.
Journal of Personalized Medicine|January 20, 2021
Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer's Disease and Frontotemporal DementiaGiulia Giacomucci, Salvatore Mazzeo, Silvia Bagnoli, et al.
Frontiers in Psychiatry|April 4, 2022
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up StudyValentina Moschini, Salvatore Mazzeo, Silvia Bagnoli, et al.
Journal of the Neurological Sciences|September 16, 2023
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive ImpairmentGiulia Giacomucci, Salvatore Mazzeo, Chiara Crucitti, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 13, 2025
The two cut-offs approach for plasma p-tau217 in detecting Alzheimer's disease in subjective cognitive decline and mild cognitive impairmentGiulia Giacomucci, Chiara Crucitti, Assunta Ingannato, et al.
Neuroimage. Clinical|August 2, 2025
Beyond language: empathy and emotion recognition deficits in primary progressive aphasiasGiulia Giacomucci, Alice Pieri, Valentina Moschini, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 17, 2026
Refining Alzheimer's disease biological diagnosis with plasma biomarkers: Resolving p-tau217 "gray zone" with p-tau181 integrationGiulia Giacomucci, Silvia Maria Rita Tabbì, Assunta Ingannato, et al.
International Journal of Molecular Sciences|July 13, 2024
Mutational Landscape of Alzheimer's Disease and Frontotemporal Dementia: Regional Variances in Northern, Central, and Southern ItalyClaudia Saraceno, Lorenzo Pagano, Valentina Laganà, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 16, 2025
"Assessing relationship between blood MAPT methylation levels and clinical expression in Frontotemporal Dementia"Gemma Lombardi, Silvia Bagnoli, Assunta Ingannato, et al.
Pageof 5